Umbilical-cord blood is increasingly used as a source of stemcells to repopulate the bone marrow in the treatment of life-threateningdiseases in children and adults (as discussed in this issueof the Journal by Laughlin et al., pages 22652275, Rochaet al., pages 22762285, and Sanz, pages 23282330).This scientific progress, however, has triggered a continuingdebate about how to organize cord-blood banks and the role ofpublic and private facilities.
The blood that remains in the placenta after birth is readilyavailable, can be collected at no risk to the mother or newborn,and may be stored frozen . . . [Full Text of this Article]
This article has been cited by other articles:
Thornley, I., Eapen, M., Sung, L., Lee, S. J., Davies, S. M., Joffe, S.
(2009). Private Cord Blood Banking: Experiences and Views of Pediatric Hematopoietic Cell Transplantation Physicians. Pediatrics
123: 1011-1017
[Abstract][Full Text]
Liao, S M, Goldschmidt, P J, Sugarman, J
(2007). Ethical and policy issues relating to progenitor-cell-based strategies for prevention of atherosclerosis. J. Med. Ethics
33: 643-646
[Abstract][Full Text]
Section on Hematology/Oncology and Section on Alle,
(2007). Cord Blood Banking for Potential Future Transplantation. Pediatrics
119: 165-170
[Abstract][Full Text]
Fraser, C. J., Hirsch, B. A., Dayton, V., Creer, M. H., Neglia, J. P., Wagner, J. E., Baker, K. S.
(2005). First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation. Blood
106: 4377-4380
[Abstract][Full Text]